"S1" . "B\u0159ezinov\u00E1, Dagmar" . "8"^^ . . . "The presence of significantly shortened telomeres are in MDS patients associated with more frequent chromosomal aberrations and with higher risk of disease progression towards advanced form of MDS and leukemic transformation. We showed that telomere dynamics might serve as useful prognostic factor for assessment of an individual MDS patient\u00B4s risk and for decision of optimal treatment strategy."@en . "Relations of telomere length in myelodysplastic syndromes and secondary acute myelogenous leukemia to karyotype and to individual risk of disease progression towards overt leukemia." . "P(NC5903), Z(MZ00237360001)" . . "9"^^ . "Leukemia Research" . "\u010Cerm\u00E1k, Jaroslav" . . . . "RIV/00023736:_____/03:00000063!RIV/2004/MZ0/L33004/N" . "0"^^ . . "0"^^ . . . . "S58;S59" . "625156" . "\u0158\u00EDhov\u00E1, Hana" . . . "Sieglov\u00E1, Zuzana" . "Zemanov\u00E1, Z." . . "Relations of telomere length in myelodysplastic syndromes and secondary acute myelogenous leukemia to karyotype and to individual risk of disease progression towards overt leukemia." . . "2"^^ . "Dvo\u0159\u00E1kov\u00E1, Ren\u00E1ta" . . . "27" . "RIV/00023736:_____/03:00000063" . . "Michalov\u00E1, Kyra" . . . "Relations of telomere length in myelodysplastic syndromes and secondary acute myelogenous leukemia to karyotype and to individual risk of disease progression towards overt leukemia."@en . "\u017Dilovcov\u00E1, So\u0148a" . "Relations of telomere length in myelodysplastic syndromes and secondary acute myelogenous leukemia to karyotype and to individual risk of disease progression towards overt leukemia."@en . "telomere; MDS; AML"@en . "GB - Spojen\u00E9 kr\u00E1lovstv\u00ED Velk\u00E9 Brit\u00E1nie a Severn\u00EDho Irska" . . "0145-2126" . "[EC3AB1DEABF1]" . . . "The presence of significantly shortened telomeres are in MDS patients associated with more frequent chromosomal aberrations and with higher risk of disease progression towards advanced form of MDS and leukemic transformation. We showed that telomere dynamics might serve as useful prognostic factor for assessment of an individual MDS patient\u00B4s risk and for decision of optimal treatment strategy." . . . "B\u0159ezinov\u00E1, Jana" .